Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
11/2003
11/13/2003WO2003068955A3 Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins
11/13/2003WO2003068804A3 Novel insect cell line
11/13/2003WO2003061365A3 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof
11/13/2003WO2003061363A3 Mutations caused by activation-induced cytidine deaminase
11/13/2003WO2003060143A3 Efficient protein expression system
11/13/2003WO2003057853A3 Oxidative stress-resistant cell lines and methods of use thereof
11/13/2003WO2003057165A3 COMPOSITIONS AND METHODS FOR PREVENTION AND TREATMENT OF AMYLOID-β PEPTIDE-RELATED DISORDERS
11/13/2003WO2003042113A8 Production of cell suspensions
11/13/2003WO2003034034A9 Automated system and method for processing multiple liquid-based specimens
11/13/2003WO2003033654A3 Direct targeting binding proteins
11/13/2003WO2003033653A3 Affinity enhancement agents
11/13/2003WO2003033463A3 Multimerized enhancer domains for cell-specific expression
11/13/2003WO2003032713A3 COFFEE PLANT WITH REDUCED α-D-GALACTOSIDASE ACTIVITY
11/13/2003WO2003031938A3 Methods, compositions, and automated systems for separating rare cells from fluid samples
11/13/2003WO2003029436A3 Ul16 binding protein 4
11/13/2003WO2003028536A3 Methods for diagnosing and treating heart disease
11/13/2003WO2003027316A3 Methods of using 33751, a human potassium channel family member
11/13/2003WO2003022215A3 Compositions and methods for priming monocytic dendritic cells and t cells for th-1 response
11/13/2003WO2003018813A3 Ashbya gossypii enzymes
11/13/2003WO2003012111A3 Conjugates for the modulation of immune responses
11/13/2003WO2003007886A3 Plant ion channels and methods
11/13/2003WO2003004605A3 Mesenchymal cells and osteoblasts from human embryonic stem cell
11/13/2003WO2002102984A3 Hdac9 polypeptides and polynucleotides and uses thereof
11/13/2003WO2002099115A3 Nucleic acid-associated proteins
11/13/2003WO2002095058A9 Emission ratiometric indicators of phosphorylation
11/13/2003WO2002095002A3 N4 virion single-stranded dna dependent rna polymerase
11/13/2003WO2002092831A3 Method for identifying ligands for g protein coupled receptors
11/13/2003WO2002090549A3 Compositions and methods for the modulation of viral maturation
11/13/2003WO2002066681A3 Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors
11/13/2003WO2002066648A3 Immunoglobulin superfamily variants expressed in mesenchymal cells and therapeutic uses thereof
11/13/2003WO2002062825A3 Detection of polymorphisms in the human 5-lipoxygenase gene
11/13/2003WO2002061033A3 Transfection of human embryonic stem cells
11/13/2003WO2002057302A8 A virus causing respiratory tract illness in susceptible mammals
11/13/2003WO2002057290A8 Novel fibronectin epitopes and proteinaceous molecules capable of binding said epitopes
11/13/2003WO2002034909A3 Engineered chimera of hiv protein fragments and uses thereof
11/13/2003WO2002032480A8 Microstructures for delivering a composition cutaneously to skin
11/13/2003WO2002032331A8 Microstructures for treating and conditioning skin
11/13/2003WO2002030443A9 Regulation of human skin healing
11/13/2003WO2002014348B1 Glycoproteins and methods of use thereof
11/13/2003WO2001090313A8 METHODS FOR ASSAYING GENE IMPRINTING AND METHYLATED CpG ISLANDS
11/13/2003WO2000021978A3 Laminin 5, 13 and 14 and uses thereof
11/13/2003US20030213016 Cyclin D polynucleotides polypeptides and uses thereof
11/13/2003US20030213009 Comprises regulatory sequences of actin deploymerizing factor (ADF) for controlling trangene expression in plants; gene expression inhibition
11/13/2003US20030213008 Method to produce cloned embryos and adults from cultured cells
11/13/2003US20030213004 Composition comprising ribozyme/monoclonal antibody fusion protein for treating cell proliferative disorders; anticarcinogenic/antiproliferative agents
11/13/2003US20030212262 Human serine racemase
11/13/2003US20030212259 Recombinant photoproteins and their conjugates
11/13/2003US20030212252 Comprises g-protein coupled receptor polypeptide, melanin-concentrating hormone receptor (MCH) for treating hypertension, diabetes, cancer, dyslipidemias, cardiovascular disease, gall stones and osteoarthritis
11/13/2003US20030212132 Determination binding of gabapentin to cells
11/13/2003US20030212040 Immobilized cell using polyglucosamine; encapsulating drug
11/13/2003US20030212026 Induce immunology response
11/13/2003US20030212024 Compositions and methods for cell dedifferentiation and tissue regeneration
11/13/2003US20030212023 Invention provides cDNAs encoding deoxyribonuclease II beta and isolated, purified deoxyribonuclease II beta proteins and antibodies against this protein and antisense agents targeted to cDNA or mRNA encoding deoxyribonuclease II beta
11/13/2003US20030212020 Antisense modulation of macrophage migration inhibitory factor expression
11/13/2003US20030212019 Hybrid nucleic acid; anticancer agents
11/13/2003US20030212018 Antisense modulation of mekk2 expression
11/13/2003US20030212017 Antisense modulation of farnesyl transferase beta subunit expression
11/13/2003US20030212000 Immunoprotective methods for beta cell neogenesis
11/13/2003US20030211996 Virus like particles
11/13/2003US20030211993 Control cell proliferation, cell differentiation; culture product
11/13/2003US20030211990 Central nervous system disorders; test kits
11/13/2003US20030211987 Dna libraries; genetic engineered nucleic acids
11/13/2003US20030211984 Genetic engineering; antibodies; libraries
11/13/2003US20030211615 System for detection of a functional interaction between a compound and a cellular signal transduction component
11/13/2003US20030211614 Using genetically engineered adeno-associated viral vector to transfer hereditary material into cells; gene therapy
11/13/2003US20030211609 Antisense modulation of ara70 expression
11/13/2003US20030211608 Antisense modulation of glycogen synthase kinase 3 beta expression
11/13/2003US20030211605 Derivation of midbrain dopaminergic neurons from embryonic stem cells
11/13/2003US20030211604 Serum-free media for chondrocytes and methods of use thereof
11/13/2003US20030211603 Using mixture of pluripotent cells to alter fate of differentiated tissues; tissue engineering; tissue regeneration
11/13/2003US20030211602 Obtaining, monitoring and differentiating between cultured pluripotent progenitor cells; for use in treatment of bone, diabetic and eating disorders; wound healing agents
11/13/2003US20030211601 Isolated bladder submucosa for tissue reconstruction
11/13/2003US20030211599 Miniature achromosomal and anucleate cell for use as drug delivery system; antitumor/antiproliferative agents
11/13/2003US20030211593 Comprises polymerase with modified exonuclease activity for use as amplification tool in DNA replication reactions
11/13/2003US20030211579 Methods for increasing polypeptide production
11/13/2003US20030211577 Novel G protein-coupled receptor, GAVE7
11/13/2003US20030211576 Comprises nucleotide sequences coding membrane protein for use in treatment of tumors and cell proliferative diseases; antiinflammatory agents
11/13/2003US20030211573 Preparing glycoprotein in cells using enhanced carbamoyl-phosphate synthase II (CPS II)/aspartate transcarbamoylase (ATCase)/dihydro-orotase (CAD) enzyme; drug delivery and design
11/13/2003US20030211571 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chrondrocytes by contacting blood with polypeptide; cancer diagnosis
11/13/2003US20030211570 Comprises nucleotide sequences coding membrane protein for use in treatment of tumors and cell proliferative diseases; antiinflammatory agents
11/13/2003US20030211569 Comprises nucleotide sequences coding membrane protein for use in treatment of tumors and cell proliferative diseases; antiinflammatory agents
11/13/2003US20030211568 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/13/2003US20030211563 Human testis specific serine/threonine kinase 1 & 2
11/13/2003US20030211542 Assays and methods of diagnosis and treatment based on use of sodium channels as targets for amyloid beta or its aggregates
11/13/2003US20030211541 Using immunological means to identify growth differentiation factor-14 (GDF-14) for treating cell proliferative and immunological disorders; gene expression inhibition; antiproliferative agents
11/13/2003US20030211540 Treatment of insulin resistance
11/13/2003US20030211529 Human Eag2
11/13/2003US20030211515 Comprises nucleotide sequences coding matrix protein for diagnosing and treating cancer
11/13/2003US20030211513 Intracellular signaling proteins
11/13/2003US20030211510 For stimulating and/or expanding T cells specific for lung tumors diagnosis, prevention and/or treatment of diseases, particularly lung cancer
11/13/2003US20030211493 Comprises membrane protein for diagnosis, prevention and treatment of infections, cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory and metabolic disorders
11/13/2003US20030211477 Carcinoembryonic antigen cell adhesion molecule 1 (CEACAM1) structure and uses thereof in drug identification and screening
11/13/2003US20030211467 Using monoclonal antibody for diagnosis, prevention and treatment of viral infections; immunotherapy; genetic vaccine
11/13/2003US20030211459 Using magnetic resonance imaging to monitor nervous system activity after exposure to agents for treatment of brain, pain and psychiatric illnesses
11/13/2003US20030211130 Bioengineered tissue substitutes
11/13/2003US20030211106 Binding tumor necrosis factor to antibody
11/13/2003US20030211101 Vascular endothelial growth factor-like protein from ORF viruses binds and activates mammalian VEGF receptor-2, and uses thereof
11/13/2003US20030211100 Gene therapy; nucleic acid coding immunoglobulins; anticancer agents
11/13/2003US20030211096 Detection of genes which amplification genome cells; anticancer, antitumor agent
11/13/2003US20030211092 Genetic engineering; gene expression; culture product
1 ... 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 1160 1161 1162 1163 1164 1165 ... 1827